These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 120869)

  • 61. Utility of Surgery/Radiotherapy in Distant Metastatic Head and Neck Squamous Cell Carcinoma: A Population-Based Approach.
    Patel TD; Marchiano E; Chin OY; Kilic S; Eloy JA; Baredes S; Park RC
    Otolaryngol Head Neck Surg; 2016 May; 154(5):868-74. PubMed ID: 26884368
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Fast neutron radiation therapy for unresectable squamous cell carcinomas of the head and neck: the results of a randomized RTOG study.
    Griffin TW; Davis R; Hendrickson FR; Maor MH; Laramore GE
    Int J Radiat Oncol Biol Phys; 1984 Dec; 10(12):2217-21. PubMed ID: 6439700
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Low dose rate irradiation of advanced head and neck cancers: present status.
    Pierquin BM; Mueller WK; Baillet F
    Int J Radiat Oncol Biol Phys; 1978; 4(7-8):565-72. PubMed ID: 711529
    [No Abstract]   [Full Text] [Related]  

  • 64. Fast neutron irradiation of metastatic cervical adenopathy: the results of a randomized RTOG study.
    Griffin TW; Davis R; Laramore GE; Hussey DH; Hendrickson FR; Rodriguez-Antunez A
    Int J Radiat Oncol Biol Phys; 1983 Sep; 9(9):1267-70. PubMed ID: 6350243
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Risk factors for local-regional recurrence following preoperative radiation therapy and surgery for head and neck cancer (stage II-IVB).
    Shikama N; Sasaki S; Nishikawa A; Koiwai K; Yoshino F; Hirase Y; Kawakami R; Kadoya M; Oguchi M
    Radiology; 2003 Sep; 228(3):789-94. PubMed ID: 12954897
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Concurrent radiation chemotherapy for locally advanced head and neck carcinoma: are we addressing burning subjects?
    Ang KK
    J Clin Oncol; 2004 Dec; 22(23):4657-9. PubMed ID: 15534361
    [No Abstract]   [Full Text] [Related]  

  • 67. The treatment of patients with stage IV squamous cell carcinoma of the head and neck: a primary radiation therapy experience in 184 cases.
    Ucmakli A
    Otolaryngol Clin North Am; 1980; 13(3):529-32. PubMed ID: 7443241
    [No Abstract]   [Full Text] [Related]  

  • 68. Clinical trials of radiation sensitizers in head and neck cancer.
    Harwood AR
    Int J Radiat Oncol Biol Phys; 1981 Dec; 7(12):1739-40. PubMed ID: 7037705
    [No Abstract]   [Full Text] [Related]  

  • 69. A multiple decision procedure in clinical trials.
    Chen TT; Simon R
    Stat Med; 1994 Mar 15-Apr 15; 13(5-7):431-46. PubMed ID: 8023027
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Regarding Maor et al. IJROBP 32(3):599-604; 1995 and Laramore and Griffin IJROBP 32 (3):879-882; 1995.
    Catterall M
    Int J Radiat Oncol Biol Phys; 1996 Mar; 34(4):969-70. PubMed ID: 8598379
    [No Abstract]   [Full Text] [Related]  

  • 71. Overcoming the Impact of Hypoxia in Driving Radiotherapy Resistance in Head and Neck Squamous Cell Carcinoma.
    Hill RM; Rocha S; Parsons JL
    Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077667
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Hyperbaric oxygenation for tumour sensitisation to radiotherapy.
    Bennett MH; Feldmeier J; Smee R; Milross C
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD005007. PubMed ID: 29637538
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Tumor oxygenation and cancer therapy-then and now.
    Hughes VS; Wiggins JM; Siemann DW
    Br J Radiol; 2019 Jan; 92(1093):20170955. PubMed ID: 29513032
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The impact of hypoxia and its modification of the outcome of radiotherapy.
    Horsman MR; Overgaard J
    J Radiat Res; 2016 Aug; 57 Suppl 1(Suppl 1):i90-i98. PubMed ID: 26983987
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Modulation of the tumor vasculature and oxygenation to improve therapy.
    Siemann DW; Horsman MR
    Pharmacol Ther; 2015 Sep; 153():107-24. PubMed ID: 26073310
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Hyperbaric oxygenation for tumour sensitisation to radiotherapy.
    Bennett MH; Feldmeier J; Smee R; Milross C
    Cochrane Database Syst Rev; 2012 Apr; 2012(4):CD005007. PubMed ID: 22513926
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The effects of hyperoxic and hypercarbic gases on tumour blood flow.
    Dunn TJ; Braun RD; Rhemus WE; Rosner GL; Secomb TW; Tozer GM; Chaplin DJ; Dewhirst MW
    Br J Cancer; 1999 Apr; 80(1-2):117-26. PubMed ID: 10389987
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The effect of hypoxia and hyperoxia on nucleoside triphosphate/inorganic phosphate, pO2 and radiation response in an experimental tumour model.
    Nordsmark M; Maxwell RJ; Horsman MR; Bentzen SM; Overgaard J
    Br J Cancer; 1997; 76(11):1432-9. PubMed ID: 9400939
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Carbogen and nicotinamide in the treatment of bladder cancer with radical radiotherapy.
    Hoskin PJ; Saunders MI; Phillips H; Cladd H; Powell ME; Goodchild K; Stratford MR; Rojas A
    Br J Cancer; 1997; 76(2):260-3. PubMed ID: 9231929
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Clinical results of hypoxic cell radiosensitisation from hyperbaric oxygen to accelerated radiotherapy, carbogen and nicotinamide.
    Saunders M; Dische S
    Br J Cancer Suppl; 1996 Jul; 27():S271-8. PubMed ID: 8763896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.